Author

Peter Irving 1

1 Guy´s and St Thomas´ Hospital Dept. of Gastroenterology - Guy´s and St Thomas´ Hospital Dep

A PROTEASE-STABILISED ORAL DOMAIN ANTIBODY TO TNF DELIVERS HIGH CONCENTRATIONS OF ACTIVE COMPOUND IN ILEAL FLUID OF SUBJECTS WITH AN ILEOSTOMY

Jan Robinson, Scott Crowe, Gary Whale, Kevin Roberts, Mike West, James Ritter, Peter Irving, Suhail Nurbhai

Investigations prior to stoma reversal in Crohn's disease: What is our current practice and does it affect outcomes?

Susanna Meade, Zillah Cargill, Amir Darakhshan, Andrew B. Williams, Joel Mawdsley, Shuvra Ray, Simon H. Anderson, Jeremy Sanderson, Peter Irving

Laboratory parameters related to monitoring in patients with ulcerative colitis treated with tofacitinib for up to 3 years in the OCTAVE open-label, long-term extension study

Gil Y. Melmed, Shannon Chang, nicole kulisek, Haiyun Fan, Nervin Lawendy, Eric Maller, Arif Soonasra, Peter Irving

THE EFFICACY OF DOSE SPLITTING THIOPURINES IN HYPERMETHYLATORS

Ben Warner, Steven Fong, Emma Johnston, Sonal Mashari, Sonal Patel, Simon H. Anderson, Peter Irving, A. Marinaki, Jeremy Sanderson

Early Use to Long Term Management with Vedolizumab: A Spotlight on UC (Takeda Pharmaceuticals International AG)

Pierre Michetti, Peter Irving, Edouard Louis

INCREASED EXPRESSION OF T-CELL-ASSOCIATED GENES IN BASELINE BIOPSIES FROM TNF ANTAGONIST NAIVE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO UNDERGO REMISSION IN RESPONSE TO ETROLIZUMAB IN A PHASE II TRIAL

Gaik Tew, Jason Hackney, Deena Gibbons, Christopher Andrew Lamb, Diana Luca, Jackson Egen, Severine Vermeire, John Charles Mansfield, Brian G. Feagan, Julian Panés, Daniel C. Baumgart, Stefan Schreiber, Iris Dotan, William Sandborn, John A. Kirby, Peter Irving, Gert De Hertogh, Gert Van Assche, Paul Rutgeerts, Sharon O'B

LOW FODMAP ADVICE FOR PATIENTS WITH IRRITABLE BOWEL SYNDROME: LONG-TERM OUTCOMES FOR SYMPTOMS AND DIETARY INTAKE

Lee Martin, Clare Jansen van Vuuren, Leah Seamark, Marianne Williams, Heidi Staudacher, Peter Irving, Kevin Whelan, Miranda Lomer

LOW FODMAP DIET & PREBIOTIC GALACTOOLIGOSACCHARIDES IMPROVE IRRITABLE BOWEL SYNDROME SYMPTOMS AND RESPONSE TO LOW FODMAP DIET IS PREDICTED BY URINE METABOLOME, STOOL SHORT-CHAIN FATTY ACIDS AND VOLATILE ORGANIC COMPOUNDS: A RANDOMISED CONTROLLED TRIAL

Peter Irving

Optimal use of conventional treatment modalities

Peter Irving

COST-UTILITY OF BIOSIMILAR INFLIXIMAB (INFLECTRA©) FOR THE TREATMENT OF LUMINAL CROHN?S DISEASE IN NINE EUROPEAN COUNTRIES

Fanni Rencz, Valentin Brodszky, Petra Baji, Marta Pentek, Laszlo Gulacsi, Petra Anna Golovics, Zsuzsanna Vegh, Krisztina Barbara Gecse, Silvio Danese, Peter Irving, Peter L Lakatos

Item 1 - 10 / 33
1
2 3 4